# Passage BIO, Inc.: Form SCHEDULE 13D, filed Jul 2, 2026

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: SCHEDULE 13D
- Filed: 2026-07-02
- Accepted by EDGAR: Jul 3, 2026, 01:19 ET
- Period: not reported
- Accession: 0000902664-26-003000
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000090266426003000/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000090266426003000/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000090266426003000/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 2, 2026.
Source: SEC EDGAR, the filing index for accession 0000902664-26-003000. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.